{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:13:49Z","timestamp":1793088829819,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3507,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1038\/sj.ki.5000404","type":"journal-article","created":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T01:54:49Z","timestamp":1318643689000},"page":"S4-S8","source":"Crossref","is-referenced-by-count":65,"special_numbering":"S101","title":["Iron indices: What do they really mean?"],"prefix":"10.1016","volume":"69","author":[{"given":"D.","family":"Coyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1038\/sj.ki.5000404_bb0010","first-page":"S182","article-title":"K\/DOQI clinical practice guidelines for anemia of chronic kidney disease","volume":"37","author":"National Kidney Foundation","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000404_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ndt\/6.1.31","article-title":"Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients","volume":"6","author":"Cannella","year":"1991","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 41","key":"10.1038\/sj.ki.5000404_bb0020","first-page":"S70","article-title":"Does anemia correction by rHuEPO improve uremic cardiopathy?","volume":"43","author":"Carletti","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000404_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end-stage renal disease with recombinant human erythropoietin","volume":"316","author":"Eschbach","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000404_bb0030","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1681\/ASN.V471455","article-title":"Effect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients","volume":"4","author":"Powe","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1038\/sj.ki.5000404_bb0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0272-6386(95)90673-8","article-title":"Cardiac function and hematocrit level","volume":"25","author":"Harnett","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000404_bb0040","first-page":"5","article-title":"The use of iron in patients on chronic dialysis: mistakes and misconceptions","volume":"11","author":"Sakiewicz","year":"1998","journal-title":"J Nephrol"},{"key":"10.1038\/sj.ki.5000404_bb0045","series-title":"Iron Metabolism and Its Disorders","first-page":"190","article-title":"Iron absorption and loss in chronic renal disease","author":"Cook","year":"1975"},{"issue":"Suppl 69","key":"10.1038\/sj.ki.5000404_bb0050","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69035.x","article-title":"Iron overload in renal failure patients: changes since the introduction of erythropoietin therapy","volume":"55","author":"Eschbach","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000404_bb0055","first-page":"2070","article-title":"Importance of iron supply for erythropoietin therapy","volume":"10","author":"Sunder-Plassmann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000404_bb0060","unstructured":"U.S. Renal Data System USRDS 1995 Annual Data Report. Atlas of End-Stage Renal Disease in the United States National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Division of Kidney, Urologic and Hematologic Diseases Bethesda, MD"},{"key":"10.1038\/sj.ki.5000404_bb0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.beha.2004.09.005","article-title":"Iron requirements in erythropoietin therapy","volume":"18","author":"Eschbach","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1038\/sj.ki.5000404_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02598003","article-title":"Laboratory diagnosis of iron-deficiency anemia: an overview","volume":"7","author":"Guyatt","year":"1992","journal-title":"J Gen Intern Med"},{"key":"10.1038\/sj.ki.5000404_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ndt\/gfg493","article-title":"Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients","volume":"19","author":"Kalantar-Zadeh","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000404_bb0080","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000404_bb0085","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1073\/pnas.161296298","article-title":"Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease","volume":"98","author":"Fleming","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5000404_bb0090","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajkd.2003.07.016","article-title":"Malnutrition\u2013inflammation complex syndrome in dialysis patients: causes and consequences","volume":"42","author":"Kalantar-Zadeh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000404_bb0095","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Kalantar-Zadeh","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1038\/sj.ki.5000404_bb0100","doi-asserted-by":"crossref","first-page":"iii3","DOI":"10.1093\/ndt\/gfh1074","article-title":"Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years","volume":"20","author":"Jacobs","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000404_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000046979","article-title":"Epidemiology of vascular disease in renal failure","volume":"20","author":"Ikizler","year":"2002","journal-title":"Blood Purif"},{"key":"10.1038\/sj.ki.5000404_bb0110","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.ASN.0000128009.69594.BE","article-title":"Administration of parenteral iron and mortality among hemodialysis patients","volume":"15","author":"Feldman","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000404_bb0115","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1046\/j.1523-1755.2001.00077.x","article-title":"A randomized trial of iron deficiency testing strategies in hemodialysis patients","volume":"60","author":"Fishbane","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000404_bb0120","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/16.7.1416","article-title":"The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin","volume":"16","author":"Tessitore","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000404_bb0125","series-title":"Hematology (Am Soc Hematol Educ Program)","first-page":"40","article-title":"Iron deficiency and overload","author":"Beutler","year":"2003"},{"key":"10.1038\/sj.ki.5000404_bb0130","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-130-12-199906150-00002","article-title":"HFE genotype in patients with hemochromatosis and other liver diseases","volume":"130","author":"Bacon","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.ki.5000404_bb0135","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM197405302902201","article-title":"A clinical evaluation of serum ferritin as an index of iron stores","volume":"290","author":"Lipschitz","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000404_bb0140","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-138-8-200304150-00008","article-title":"Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis","volume":"138","author":"Morrison","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.ki.5000404_bb0145","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0016-5085(98)70265-3","article-title":"Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis","volume":"115","author":"Guyader","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1038\/sj.ki.5000404_bb0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5414\/CNP57136","article-title":"Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients","volume":"57","author":"Chang","year":"2002","journal-title":"Clin Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815513975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815513975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T21:11:52Z","timestamp":1639170712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815513975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":29,"alternative-id":["S0085253815513975"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5000404","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}